Vertically acquired paediatric coinfection with HIV and hepatitis C virus

Lancet Infectious Diseases

Volumn 6, Issue 2, 2006, Pages 83-90

  England, Kirsty ^a   Thorne, Claire ^a   Newell, Marie Louise ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PEGINTERFERON ALPHA2B; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ANEMIA; CLINICAL FEATURE; DELIVERY; DEPRESSION; DISEASE COURSE; FATIGUE; FEVER; HAIR LOSS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; MITOCHONDRIAL TOXICITY; MYALGIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; PREGNANCY; RISK FACTORS;

EID: 31344479610     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(06)70381-4     Document Type: Review

References (68)

1. I Bica, B McGovern, R Dhar Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection Clin Infect Dis 32 2001 492 497
2. M Bonacini, M Puoti Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues Arch Intern Med 160 2000 3365 3373
3. N Qurishi, C Kreuzberg, G Luchters Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection Lancet 362 2003 1708 1713
4. E Rosenthal, M Poiree, C Pradier Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) AIDS 17 2003 1803 1809
5. JK Rockstroh, U Spengler HIV and hepatitis C virus co-infection Lancet Infect Dis 4 2004 437 444
6. P Braitstein, A Palepu, D Dieterich, Y Benhamou, JS Montaner Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C AIDS 18 2004 2221 2234
7. MS Sulkowski, SH Metha, M Torbenson Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus AIDS 19 2005 585 592
8. R Nduati, G John, D Mbori-Ngacha Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial JAMA 283 2000 1167 1174
9. ML Newell Mechanisms and timing of mother-to-child transmission of HIV-1 AIDS 12 1998 831 837
10. C Thorne, ML Newell Epidemiology of HIV infection in the newborn Early Hum Dev 58 2000 1 16
11. CM Wilfert, JS Stringer Prevention of pediatric human immunodeficiency virus Semin Pediatr Infect Dis 15 2004 190 198
12. G Scarlatti Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries AIDS Rev 6 2004 67 78
13. LM Mofenson Advances in the prevention of vertical transmission of human immunodeficiency virus Semin Pediatr Infect Dis 14 2003 295 308
14. ML Newell Prevention of mother-to-child transmission of HIV: challenges for the current decade Bull World Health Organ 79 2001 1138 1144
15. M Giovannini, A Tagger, ML Ribero Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction Lancet 335 1990 1166
16. RC Hershow, KA Riester, J Lew Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers J Infect Dis 176 1997 414 420
17. S Paccagnini, N Principi, E Massironi Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population Pediatr Infect Dis J 14 1995 195 199
18. V Papaevangelou, H Pollack, G Rochford Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women J Infect Dis 178 1998 1047 1052
19. DL Thomas, SA Villano, KA Riester Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers J Infect Dis 177 1998 1480 1488
20. PA Tovo, E Palomba, G Ferraris Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1 Clin Infect Dis 25 1997 1121 1124
21. G Nigro, F D'Orio, S Catania Mother to infant transmission of coinfection by human immunodeficiency virus and hepatitis C virus: prevalence and clincial manifestations Arch Virol 142 1997 453 457
22. AR Zanetti, E Tanzi, L Romano A prospective study on mother-to-infant transmission of hepatitis C virus Intervirology 41 1998 208 212
23. DM Gibb, RL Goodall, DT Dunn Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission Lancet 356 2000 904 907
24. European Paediatric HCV Network L Pembrey, PA Tovo, ML Newell Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus Br J Obstet Gynaecol 108 2001 371 377
25. S Ferrero, P Lungaro, BM Bruzzone, C Gotta, G Bentivoglio, N Ragni Prospective study of mother-to-infant transmission of hepatitis C virus: a 10-year survey (1990-2000) Acta Obstet Gynecol Scand 82 2003 229 234
26. EM Connor, RS Sperling, R Gelber Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl J Med 331 1994 1173 1180
27. European Paediatric HCV Network PA Tovo, L Pembrey, ML Newell A significant gender, but not elective caesarean section effect on mother-to-child transmission of hepatitis C virus infection J Infect Dis 192 2005 1872 1879
28. MO Granovsky, HL Minkoff, BH Tess Hepatitis C virus infection in the mothers and infants cohort study Pediatrics 102 1998 355 359
29. M Resti, C Azzari, F Mannelli Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1 BMJ 317 1998 437 441
30. SL Thomas, ML Newell, CS Peckham, AE Ades, AJ Hall A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection Int J Epidemiol 27 1998 108 117
31. A Ruiz-Extremera, J Salmeron, C Torres Follow-up of transmission of hepatitis C to babies of human immunodeficiency virus-negative women: the role of breast-feeding in transmission Pediatr Infect Dis J 19 2000 511 516
32. J Mok, L Pembrey, PA Tovo, ML Newell When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed 90 2005 F156 F160
33. The French Pediatric HIV Infection Study Group and European Collaborative Study Morbidity and mortality in European children vertically infected by HIV-1 J Acquir Immune Defic Syndr Hum Retrovirol 14 1997 442 450
34. European Collaborative Study Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected children AIDS 18 2004 509 516
35. European Collaborative Study Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life Pediatrics 108 2001 116 122
36. CT Staples, D Rimland, D Dudas Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival Clin Infect Dis 29 1999 150 154
37. M Dorrucci, P Pezzotti, AN Phillips, AC Lepri, G Rezza Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS (Italian Seroconversion Study) J Infect Dis 172 1995 1503 1508
38. MS Sulkowski, RD Moore, SH Mehta, RE Chaisson, DL Thomas Hepatitis C and progression of HIV disease JAMA 288 2002 199 206
39. Rockstroh J, Konopnicki D., Soriano V. Hepatitis B and hepatitis C in the EuroSIDA cohort: prevalence and effect on mortality, AIDS, progression and response to HAART. 11th Conference on Retroviruses and Opportunistic Infections; San Fransisco, CA, USA; Feb 8-11, 2004. Abstract 799.
40. MJ Carlos, J Castilla, M Lopez, R Arranz, J Gonzalez-Lahoz, V Soriano Impact of chronic hepatitis C on HIV-1 disease progression HIV Clin Trials 5 2004 125 131
41. G Greub, B Ledergerber, M Battegay Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Lancet 356 2000 1800 1805
42. TW Yoo, S Donfield, A Lail, HS Lynn, ES Daar Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease J Infect Dis 191 2005 4 10
43. European Paediatric HCV Network Three broad modalities in the natural history of vertically acquired hepatitis C virus infection Clin Infect Dis 41 2005 45 51
44. AH Mohsen, P Easterbrook, CB Taylor, S Norris Hepatitis C and HIV-1 coinfection Gut 51 2002 601 608
45. KE Nelson, DL Thomas Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections Clin Diagn Lab Immunol 8 2001 867 870
46. EM Tedaldi, RK Baker, AC Moorman Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy Clin Infect Dis 36 2003 363 367
47. D Fuster, R Planas, R Muga Advanced liver fibrosis in HIV/HCV coinfected patients on antiretroviral therapy AIDS Res Hum Retroviruses 20 2004 1293 1297
48. G Mathews, S Bhagani The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections J HIV Ther 8 2003 77 84
49. M Guido, M Rugge, P Jara Chronic hepatitis C in children: the pathological and clinical spectrum Gastroenterology 115 1998 1525 1529
50. C Garcia-Monzon, P Jara, M Fernandez-Bermejo Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients Hepatology 28 1998 1696 1701
51. G Borgia, L Reynaud, I Gentile, M Piazza HIV and hepatitis C virus: facts and controversies Infection 31 2003 232 240
52. A Alberti, N Clumeck, S Collins Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients J Hepatol 42 2005 615 624
53. C Tural, D Fuster, J Tor Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients J Viral Hepat 10 2003 118 125
54. MP Manns, H Wedemeyer Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step JAMA 292 2004 2909 2913
55. J Macias, V Castellano, N Merchante Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine AIDS 18 2004 767 774
56. F Carrat, F Bani-Sadr, S Pol Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial JAMA 292 2004 2839 2848
57. RT Chung, J Andersen, P Volberding Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons N Engl J Med 351 2004 451 459
58. M Laguno, J Murillas, JL Blanco Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients AIDS 18 2004 F27 F36
59. FJ Torriani, M Rodriguez-Torres, JK Rockstroh Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
60. DB Strader, T Wright, DL Thomas, LB Seeff Diagnosis, management, and treatment of hepatitis C Hepatology 39 2004 1147 1171
61. AA Butt Hepatitis C virus infection: the new global epidemic Expert Rev Anti Infect Ther 3 2005 241 249
62. National Institute for Clinical Excellence Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C http://www.nice.org.uk/pdf/TA075guidance.pdf (accessed Dec 16, 2005)
63. British HIV Association (BHIVA) BHIVA guidelines http://www.bhiva.org/ guidelines/2005/BHIVA-guidelines/DRAFT-2005.pdf (accessed Dec 16, 2005)
64. US Department of Health and Human Services Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Developed by the Panel on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Services, USA http://aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL.pdf October 6, 2005 (accessed Jan 4, 2006)
65. European AIDS Clinical Society European guidelines for the clinical management and treatment of HIV infected adults in Europe http://www.eacs.ws/ download/European_Treatment_Guidelines.pdf 2001 (accessed Dec 16, 2005)
66. M Nelson, G Mathews, MG Brook, J Main the BHIVA Coinfection Committee on behalf of the British HIV Association BHIVA guidelines on HIV and chronic hepatitis: coinfection with HCV and hepatitis C virus infection (2005) HIV Med 6 suppl 2 2005 96 106
67. S Wirth, H Pieper-Boustani, T Lang Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C Hepatology 41 2005 1013 1018
68. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children Guidelines for the use of antiretroviral agents in paediatric HIV infection http://aidsinfo.nih.gov/ContentFiles/ PediatricGuidelines.pdf March 2005 (accessed Jan 4, 2006)